Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane

Japanese Journal of Cancer Research

Volumn 90, Issue 4, 1999, Pages 406-412

  Yoshimi, Naoki ^a   Shimizu, Masahito ^a   Matsunaga, Kengo ^a   Yamada, Yasuhiro ^a   Fujii, Keiko ^a   Hara, Akira ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoprevention; Cyclooxygenase 2; Rat colon carcinogenesis

Indexed keywords

AZOXYMETHANE; CELL NUCLEUS ANTIGEN; CYCLOOXYGENASE 2 INHIBITOR; GUM ARABIC; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; COLON CARCINOGENESIS; CONTROLLED STUDY; FEEDING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STOMACH ULCER;

EID: 0032929712     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00762.x     Document Type: Article

References (48)

1. Broder, S. Perspectives on cancer in Japan and the United States. Jpn. J. Cancer Res., 83, 821-830 (1993).
2. Sandler, R. S., DeVellis, B. M., Blalock, S. J. and Holland, K. L. Participation of high-risk subjects in colon cancer screening. Cancer, 63, 2211 -2215 (1989).
3. Guillem, J. G., Forde, K. A., Treat, M. R., Neugut, A. I., O'Toole, K. M. and Diamond, B. E. Colonoscopic screening for neoplasms in asymptomatic first-degree relatives of colon cancer patients. A controlled, prospective study. Dis. Colon Rectum, 35, 523-529 (1992).
4. Waddell, W. R. and Loughry, R. W. Sulindac for polyposis of the colon. J. Surg. Oncol., 24, 83-87 (1983).
5. Thun, M. J., Namboodiri, M. N. and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325, 1593-1596 (1991).
6. Gann, P. H., Manson, J. E., Glynn, R. J., Buring, J. E. and Hennekens, C. H. Low dose aspirin and incidence of colorectal tumours in a randomized trial. J. Natl. Cancer Inst., 85, 1220-1224 (1993).
7. Tanaka, T., Kojima, T., Yoshimi, N., Sugie, S. and Mori, H. Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin, on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats. Carcinogenesis, 12, 1949-1952 (1991).
8. Reddy, B. S., Rao, C. V., Rivenson, A. and Kelloff, G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis, 14, 1493-1497 (1993).
9. Rao, C. V., Rivenson, A., Simi, B., Zang, E., Kelloff, G., Steele, V. and Reddy, B. S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent. Cancer Res., 55, 1464-1472 (1995).
10. Beazer-Barclay, Y., Levy, D. B., Moser, A. R., Dove, W. F., Hamilton, S. R., Volgelstein, B. and Kinzler, K. W. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis, 17, 1757-1760 (1996).
11. Jacoby, R. F., Marshall, D. J., Newton, M. A., Novakovic, K., Tutsch, K., Cole, C. E., Lubet, R. A., Kellof, G. J., Verma, A., Moser, A. R. and Dove, W. F. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the non-steroidal anti-inflammatory drug piroxicam. Cancer Res., 56, 710-714 (1996).
12. Smith, W. L. and Marnett, L. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta, 1083, 1-17 (1991).
13. Feng, L., Sun, W., Xia, Y., Tang, W. W., Chanmugam, P., Soyoola, E., Wilson, C. B. and Hwang, D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch. Biochem. Biophys., 307, 361-368 (1993).
14. Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W. and Herschman, H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. Biol. Chem., 266, 12866-12872 (1991).
15. Hla, T. and Neilson, K. Human cyclooxygenase-2 cDNA. Proc. Natl. Acad. Sci. USA, 89, 7384-7388 (1992).
16. Hla, T., Kistimaki, A., Appleby, S. and Barriocanel, J. G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann. NY Acad. Sci., 696, 197-204 (1993).
17. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S. and DuBois, R. N. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
18. Sano, H., Kawahito, Y., Wilder, R.L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M. and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55, 3785-3789 (1995).
19. Yoshimi, N., Ino, N., Suzui, M., Tanaka, T., Nakashima, S., Nakamura, M., Nozawa, Y. and Mori, H. The mRNA overexpression of inflammatory enzymes, phospholipase A2 and cyclooxygenase, in the large bowel mucosa and neoplasms of F344 rats treated with naturally occurring carcinogen, 1-hydroxyanthraquinone. Cancer Lett., 97, 75-82 (1995).
20. DuBois, R. N., Radhika, A., Reddy, B. S. and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat clonic tumors. Gastroenterology, 110, 1259-1262 (1996).
21. Vane, J. R. and Botting, R. M. Overview - mechanisms of action of anti-inflammatory drugs. In "Improved Non-steroidal Anti-inflammatory Drugs: COX-2 Enzyme Inhibitors," ed. J. Vane, J. Botting, and R. Botting, pp. 1-27 (1996). Kluwer Academic Publishers, Dordrecht.
22. Takahashi, M., Fukutake, M., Yokota, S., Ishida, K., Wakabayashi, K. and Sugimura, T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclo-oxygenase-2. J. Cancer Res. Clin. Oncol., 122, 733-737 (1996).
23. Reddy, B. S., Rao, C. V. and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis,. Cancer Res., 56, 4566-4569 (1996).
24. Yoshimi, N., Kawabata, K., Hara, A., Matsunaga, K., Yamada, Y. and Mori, H. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. Jpn. J. Cancer Res., 88, 1044-1051 (1997).
25. Ward, J. M. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest., 30, 505-513 (1974).
26. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151 (1987).
27. Wang, A., Yoshimi, N., Tanaka, T. and Mori, H. Inhibitory effects of magnesium hydroxide on c-myc expression and cell proliferation induced by methylazoxymethanol acetate in rat colon. Cancer Lett., 75, 73-78 (1993).
28. Mori, H., Mori, Y., Tanaka, T., Yoshimi, N., Sugie, S., Kawamori, T. and Narisawa, T. Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats. Carcinogenesis, 13, 2217-2220 (1992).
29. Dewitt, D. L., Day, J., Sonnenberg, W. K. and Smith, W. L. Concentration of prostaglandin endoperoxide synthase and prostaglandin 12 synthase in the endothelium and smooth muscle of bovine aorta. J. Clin. Invest., 72, 1882-1888 (1983).
30. Futaki, N., Arai, I., Hamasaka, Y., Takahashi, S., Higuchi, S. and Otomo, S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat-carrageenan-airpouch inflammation. J. Pharm. Pharmatol., 45, 753-755 (1993).
31. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S. and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/ cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47, 55-59 (1994).
32. Huff, R., Collins, P., Kramer, S., Seibert, K., Koboldt, C., Gregory, S. and Isakson, P. A structural feature of N-[2-(cyclohexyloxy)-4-nitrophenyl]methanesulfonamide (NS-398) that governs its selectivity and affinity for cyclooxygenase 2 (COX2). Inflamm. Res., 44 (Suppl. 2), S145-8146 (1994).
33. Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H. and Otomo, S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and anti-pyretic effects, which causes minimal stomach lesions. Gen. Pharmacol. 24, 105-110 (1993).
34. Arai, I., Hamasaka, Y., Futaki, N., Takahashi, S., Yoshikawa, K., Higuchi, S. and Otomo, S. Effect of NS-398, a new nonsteroidal anti-inflammatory agent, on gastric ulceration and acid secretion in rats. Res. Commun. Chem. Pathol. Pharmacol., 81, 259-270 (1993).
35. Hirata, T., Ukawa, H., Kitamura, M. and Takeuchi, K. Effects of selective cyclooxygenase-2 inhibitors on alkaline secretory and mucosal ulcerogenic responses in rat duodenum. Life Sci., 61, 1603-1611 (1997).
36. Kawamori, T., Rao, C. V., Seibert, K. and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res., 58, 409-412 (1998).
37. Nakatsugi, S., Fukutake, M., Takahashi, M., Fukuda, K., Isoi, T., Taniguchi, Y., Sugimura, T. and Wakabayashi, K. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn. J. Cancer Res., 88, 1117-1120 (1997).
38. Fukutake, M., Nakatsugi, S., Isoi, T., Takahashi, M., Ohta, T., Mamiya, S., Taniguchi, Y., Sato, H., Fukuda, K., Sugimura, T. and Wakabayashi, K. Suppressive effects of nimesulide, a selective inhibitor of cyclooxygenase-2, on azoxymethane-induced colon carcinogenesis in mice. Carcinogenesis, 19, 1939-1942 (1998).
39. Okajima, E., Denda, A., Ozono, S., Takahama, M., Akai, H., Sasaki, Y., Kitayama, W., Wakabayashi, K. and Konishi, Y. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine. Cancer Res., 58, 3028-3031 (1998).
40. Oshima, M., Dinchuk, J. E., Kargman, S., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F. and Taketo, M. M. Suppression of intestinal polyps in Apc D761 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 87, 803-809 (1996).
41. Tsujii, M. and DeBois, R. N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell. 83, 493-501 (1995).
42. DuBois, R. N., Shao, J. Y., Tsujii, M., Sheng, H. M. and Beauchamp, R. D. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56, 733-737 (1996).
43. Hara, A., Yoshimi, N., Niwa, M., Ino, N. and Mori, H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res., 88, 600-604 (1997).
44. Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Gunawan, E. S., Takei, Y., Nagano, K. and Mori, M. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am. J. Physiol., 274, G1061-G1067 (1998).
45. Lin, X.-H., Yao, S., Kirschenbaum, A. and Levine, A. C. NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58, 4245-4249 (1998).
46. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M. and DuBois, B. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93, 705-716 (1998).
47. Elder, D. J. E., Hague, A., Hicks, D. J. and Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro transformed adenoma relative to adenoma cell lines. Cancer Res., 56, 2273-2276 (1996).
48. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staino-Coico, L., Shiff, S. I. and Rigas, B. Effects of non-steroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin independent pathway. Biochem. Pharmacol., 52, 237-245 (1996).